BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23260058)

  • 1. Effects of familial mutations on the monomer structure of Aβ₄₂.
    Lin YS; Pande VS
    Biophys J; 2012 Dec; 103(12):L47-9. PubMed ID: 23260058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer.
    Lin YS; Bowman GR; Beauchamp KA; Pande VS
    Biophys J; 2012 Jan; 102(2):315-24. PubMed ID: 22339868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides.
    Chong SH; Yim J; Ham S
    Mol Biosyst; 2013 May; 9(5):997-1003. PubMed ID: 23358498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes to the structure and dynamics in mutations of Aβ(21-30) caused by ions in solution.
    Smith MD; Cruz L
    J Phys Chem B; 2013 Dec; 117(48):14907-15. PubMed ID: 24261958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Alzheimer's Disease-Related Mutations Differentially Alter Stability of Amyloid-Beta Aggregates.
    Rezaei-Ghaleh N; Amininasab M; Giller K; Becker S
    J Phys Chem Lett; 2023 Feb; 14(6):1427-1435. PubMed ID: 36734539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's protective A2T mutation changes the conformational landscape of the Aβ₁₋₄₂ monomer differently than does the A2V mutation.
    Das P; Murray B; Belfort G
    Biophys J; 2015 Feb; 108(3):738-47. PubMed ID: 25650940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the familial Dutch mutation E22Q in the folding and aggregation of the 15-28 fragment of the Alzheimer amyloid-beta protein.
    Baumketner A; Krone MG; Shea JE
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6027-32. PubMed ID: 18408165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
    Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
    J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Arctic mutation alters helix length and type in the 11-28 beta-amyloid peptide monomer-CD, NMR and MD studies in an SDS micelle.
    Rodziewicz-Motowidło S; Czaplewska P; Sikorska E; Spodzieja M; Kołodziejczyk AS
    J Struct Biol; 2008 Nov; 164(2):199-209. PubMed ID: 18765285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of familial Alzheimer's disease mutations on the folding nucleation of the amyloid beta-protein.
    Krone MG; Baumketner A; Bernstein SL; Wyttenbach T; Lazo ND; Teplow DB; Bowers MT; Shea JE
    J Mol Biol; 2008 Aug; 381(1):221-8. PubMed ID: 18597778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral amyloid angiopathy-linked β-amyloid mutations promote cerebral fibrin deposits via increased binding affinity for fibrinogen.
    Cajamarca SA; Norris EH; van der Weerd L; Strickland S; Ahn HJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14482-14492. PubMed ID: 32518112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Alzheimer's disease mutations alter the stability of the amyloid beta-protein monomer folding nucleus.
    Grant MA; Lazo ND; Lomakin A; Condron MM; Arai H; Yamin G; Rigby AC; Teplow DB
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16522-7. PubMed ID: 17940047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation.
    Tsubuki S; Takaki Y; Saido TC
    Lancet; 2003 Jun; 361(9373):1957-8. PubMed ID: 12801742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the role of sidechain size and charge in the aggregation of A
    Yang X; Meisl G; Frohm B; Thulin E; Knowles TPJ; Linse S
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5849-E5858. PubMed ID: 29895690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational Characterization of Native and L17A/F19A-Substituted Dutch-Type β-Amyloid Peptides.
    He KC; Chen YR; Liang CT; Huang SJ; Tzeng CY; Chang CF; Huang SJ; Huang HB; Lin TH
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single point mutation alters the microstate dynamics of amyloid β-protein Aβ42 as revealed by dihedral dynamics analyses.
    Xu L; Shan S; Wang X
    J Phys Chem B; 2013 May; 117(20):6206-16. PubMed ID: 23662730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors.
    Chakraborty S; Das P
    Sci Rep; 2017 Aug; 7(1):9941. PubMed ID: 28855598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of G33A and G33I mutations on the structures of monomer and dimer of the amyloid-β fragment 29-42 by replica exchange molecular dynamics simulations.
    Lu Y; Wei G; Derreumaux P
    J Phys Chem B; 2011 Feb; 115(5):1282-8. PubMed ID: 21186801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PITRM1 interaction studies with amyloidogenic nonapeptide mutants of familial Alzheimer's disease.
    Wilson Alphonse CR; Rajesh Kannan R; Nagarajan N
    J Biomol Struct Dyn; 2023; 41(12):5660-5671. PubMed ID: 35751131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.